Mandatory Joint Clinical Assessments For EU HTAs May Be ‘Counterproductive’
The mandatory joint clinical assessments that the European Commission recently proposed for EU member states will be counterproductive if the highest standards of evaluation are not met, warns Health Action International.
You may also be interested in...
Draft proposals to improve EU-wide cooperation on health technology assessments, including mandatory joint clinical assessments, have won support from EFPIA, the European Federation of Pharmaceutical Industries and Associations.
A Dutch parallel registration and reimbursement pilot has brought benefits including more participation from healthcare professionals, and also forces company divisions to be less streamlined.
The UK’s withdrawal from the EU could upset the Unitary Patent Court project.